Prior studies identified a cell-surface antigen, p75/150, that Many markers of malignancy can be characterized as cellsurface phenotypic changes (1). As such, they represent important tools for identifying critical events in tumorigenesis and potentially useful clinical applications. Studies such as those involving somatic cell hybridization have demonstrated that transformation and tumorigenicity are phenotypically distinct (2). From these studies, many classical markers of malignancy have been shown not to correlate exclusively with the tumorigenic phenotype, but rather are markers associated with preneoplastic transformation. Our aim has been to focus on events that are specifically required for tumorigenicity by examining an authentic tumor marker of HeLa x fibroblast (H/F) hybrids, p75/150.In previous work, stably suppressed nontumorigenic hybrids were generated from a HeLa x normal human fibroblast fusion (3). Interestingly, the hybrids still exhibited transformed behavior in culture. Rare tumorigenic segregant subpopulations arose from these hybrids, which had gained the ability to form tumors in athymic nude mice (4). Comparative analyses have shown that the nontumorigenic hybrids and tumorigenic segregants have many similar properties in vitro, such as anchorage independence (5), growth rate, cytoskeletal and cell-surface characteristics (4), and expression of various protooncogenes (6). The noted differences found in the tumorigenic segregants were expression of a cell-surface antigen, p75/150 (7), the a subunit of human chorionic gonadotropin (8), and the Ca antigen (9).The p75/150 antigen was identified by using a polyclonal antiserum that had been raised against a tumorigenic segregant cell line and extensively cross-adsorbed with nontumorigenic hybrid cells (7). p75/150 was abundantly expressed on the cell surfaces of the tumorigenic HeLa parents and the tumorigenic segregants; however, it was not detected on either the fibroblast parents or the nontumorigenic cell hybrids. In radiobiological studies involving the H/F cell hybrids, nontumorigenic hybrid cells were treated with ionizing y-radiation and screened for p75/150 expression (10,11). In all cases, the various isolates expressing p75/150 were found to be tumorigenic in athymic nude mice (ref. 11; E.J.S. and J. L. Redpath, unpublished data). Thus, there is a strong correlation between reexpression of both p75/150 and tumorigenicity in the H/F cell hybrids, and this correlation is observed following selection of either trait.Initial characterization of p75/150 identified it as a 75-kDa membrane-bound, glycosylated phosphoprotein, with an apparent molecular mass of 150 kDa under nonreducing conditions (7,12). The specificity of the p75/150 marker for the tumorigenic phenotype suggests that it may play a direct role in the tumorigenic behavior of the H/F cell hybrids. Several of the properties associated with p75/150, such as its localization to the cell membrane and apparent autophosphorylation activity (7,12), are shared by a number ...